81 related articles for article (PubMed ID: 38467448)
1. Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development.
Gao W; Liu J; Shtylla B; Venkatakrishnan K; Yin D; Shah M; Nicholas T; Cao Y
CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):691-709. PubMed ID: 37969061
[TBL] [Abstract][Full Text] [Related]
2. Challenges in Expediting the Development of Oncology Drugs.
Noguchi E; Yaginuma H; Fujiwara Y
JCO Oncol Pract; 2023 Apr; 19(4):216-217. PubMed ID: 36657099
[No Abstract] [Full Text] [Related]
3. Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols.
Khan T; Stewart M; Blackman S; Rousseau R; Donoghue M; Cohen K; Seibel N; Fleury M; Benettaib B; Malik R; Vassal G; Reaman G
Ther Innov Regul Sci; 2019 Mar; 53(2):270-278. PubMed ID: 29759018
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress.
Charlab R; Leong R; Shord SS; Reaman GH
Cold Spring Harb Perspect Med; 2024 Apr; 14(4):. PubMed ID: 38467448
[TBL] [Abstract][Full Text] [Related]
5. Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.
Barry E; Walsh JA; Weinrich SL; Beaupre D; Blasi E; Arenson DR; Jacobs IA
Paediatr Drugs; 2021 Jul; 23(4):381-394. PubMed ID: 34173206
[TBL] [Abstract][Full Text] [Related]
6. New approaches to therapeutic drug development for childhood cancers.
Campbell K; Ma C; DuBois SG
Curr Opin Pediatr; 2020 Feb; 32(1):35-40. PubMed ID: 31790026
[TBL] [Abstract][Full Text] [Related]
7. Evolving paradigms for new agent development in pediatric oncology.
Flynn A; Fox E
Curr Opin Pediatr; 2018 Feb; 30(1):10-16. PubMed ID: 29176356
[TBL] [Abstract][Full Text] [Related]
8. Opportunities and Challenges in Drug Development for Pediatric Cancers.
Laetsch TW; DuBois SG; Bender JG; Macy ME; Moreno L
Cancer Discov; 2021 Mar; 11(3):545-559. PubMed ID: 33277309
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
